Clinical Trial Update: Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update describes the immunogenicity and safety evaluation of the investigational hepatitis A vaccine I-HAV in healthy Thai children …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• I-HAV
• L-HAV

Snippet

Sponsor: Chiang Mai University | Conditions: Hepatitis A, Hepatitis A Virus | Phase 3 | Status: RECRUITING